1. Home
  2. PODD vs LDOS Comparison

PODD vs LDOS Comparison

Compare PODD & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • LDOS
  • Stock Information
  • Founded
  • PODD 2000
  • LDOS 1969
  • Country
  • PODD United States
  • LDOS United States
  • Employees
  • PODD N/A
  • LDOS N/A
  • Industry
  • PODD Medical/Dental Instruments
  • LDOS EDP Services
  • Sector
  • PODD Health Care
  • LDOS Technology
  • Exchange
  • PODD Nasdaq
  • LDOS Nasdaq
  • Market Cap
  • PODD 22.1B
  • LDOS 21.0B
  • IPO Year
  • PODD 2007
  • LDOS 2006
  • Fundamental
  • Price
  • PODD $338.05
  • LDOS $194.21
  • Analyst Decision
  • PODD Strong Buy
  • LDOS Strong Buy
  • Analyst Count
  • PODD 19
  • LDOS 12
  • Target Price
  • PODD $346.95
  • LDOS $204.91
  • AVG Volume (30 Days)
  • PODD 541.9K
  • LDOS 770.5K
  • Earning Date
  • PODD 11-06-2025
  • LDOS 11-04-2025
  • Dividend Yield
  • PODD N/A
  • LDOS 0.89%
  • EPS Growth
  • PODD N/A
  • LDOS 22.34
  • EPS
  • PODD 3.45
  • LDOS 10.68
  • Revenue
  • PODD $2,521,800,000.00
  • LDOS $17,332,000,000.00
  • Revenue This Year
  • PODD $29.32
  • LDOS $5.17
  • Revenue Next Year
  • PODD $18.37
  • LDOS $3.59
  • P/E Ratio
  • PODD $94.55
  • LDOS $18.07
  • Revenue Growth
  • PODD 27.11
  • LDOS 6.48
  • 52 Week Low
  • PODD $230.05
  • LDOS $123.62
  • 52 Week High
  • PODD $353.50
  • LDOS $205.77
  • Technical
  • Relative Strength Index (RSI)
  • PODD 63.74
  • LDOS 53.82
  • Support Level
  • PODD $311.51
  • LDOS $193.05
  • Resistance Level
  • PODD $335.00
  • LDOS $200.46
  • Average True Range (ATR)
  • PODD 11.39
  • LDOS 5.67
  • MACD
  • PODD 1.60
  • LDOS 0.27
  • Stochastic Oscillator
  • PODD 96.74
  • LDOS 47.66

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Share on Social Networks: